Articles | Apodi

Patient Programmes: Driving Implementation Through Effective Leadership - Watch Out for the Hidden Human Factors

October 2024

Executing Patient Support Programmes (PSPs) typically involves navigating hidden human factors that can significantly impact patient outcomes. Issues like cultural misalignments, leadership failures, and stakeholder mismanagement add to the complexity. This article explores how leaders can foster innovation and collaboration to overcome these challenges and make a significant impact.

Patient Programmes: Getting it Right Early is Critical for Long Term Success

October 2024

Discover how tackling key challenges in the early stages of Patient Support Programme (PSP) implementation, can ensure long-term success, as well as benefits for patients, the NHS, and pharmaceutical companies.

Eliminating Blocks and Driving Access to Medicine - A Focus on Local Healthcare Economies

September 2024

Pharmaceutical companies invest heavily in research, development, and commercialisation of medicines, but local care pathway challenges can undermine these efforts. Medicines often remain unused due to obstacles like insufficient medical staff, lack of facilities, and inadequate patient scheduling processes. This edition of Apodi’s ’Market Leadership’ article-series examines strategies to overcome these challenges and ensure patients receive the care they need.

Patient Programmes - Navigating Challenges for Transformational Outcomes

August 2024

Navigating the complexities of the NHS requires pharmaceutical companies to enhance patient experience, improve treatment accessibility, and provide personalised care. With waiting lists continuing to grow, how can effective Patient Programmes address these challenges and make a significant impact?

Oncology - A Fiercely Competitive Landscape for Pharma

June 2024

Explore how tailored Patient Support Programmes (PSPs) can transform Oncology care by addressing local needs and improving patient outcomes; thereby, driving a significant impact on NHS cancer services.

Maximise NHS Impact and Brand Value

May 2024

Brand positioning is a complex process for pharmaceutical companies, particularly when navigating the intricate landscape of the NHS. With waiting lists continuing to grow, how can Patient Support Programs (PSPs) make a difference?

Generating Deep Insight To Improve Access To Medicines

April 2024

Discover how Apodi’s highly innovative new model has the potential to revolutionise insight activities within pharmaceutical companies, thereby enhancing patient access to medicines.

How to Ensure Patients Access Patient Programmes

October 2023

Apodi’s latest article explores how pharmaceutical companies can accelerate access to their medicines through Patient Programmes and ensure that all eligible patients have access to these Programmes.

Driving Local and National Coverage

September 2023

Drive access to your medicines through accelerated local and national coverage of your Patient Programmes.

Capacity Busting Programmes: Driving access to your medicines

June 2023

Driving access to their medicines continues to be a major challenge for many pharmaceutical companies. Waiting lists of approx. 7 million patients in the NHS makes this challenge even greater. Apodi’s latest article explores possible short-term solutions to help navigate this complex marketplace positively impacting on patient care and reducing waiting lists.

Evaluation & Monitoring – Early & Always

March 2023

In the final article of Apodi’s ‘The Block Series - Driving Access to Medicines’, we look specifically at the evaluation and monitoring of Patient Support Programmes. Ensuring that results are driven from the off and continuous improvement is imbedded throughout the Programme.

Team Effectiveness & Pareto’s Principle

February 2023

Differing levels of performance in Trust Engagement have a dramatic effect on the success or otherwise on Patient Programme implementation. Find out why in Apodi’s latest insight article.

Executing Patient Programmes Effectively & Quickly

January 2023

In order to execute Patient Programmes effectively and quickly, it is imperative to understand at the onset where execution issues are likely to occur and thus plan appropriate interventions from the start. In this article, Apodi addresses the key aspects and challenges of executing Patient Programmes effectively and quickly.

Patient Programmes: How to Customise Solutions to Localities

December 2022

Patient Programmes need to be customised and flexed to meet specific needs of customers (e.g., Trusts). Companies that can successfully customise and flex a Programme to meet the needs of specific localities will perform more effectively than those that do not – i.e., drive access to their medicines.

What to do about the Block(s)?

November 2022

Patient Programmes can turbo charge access to a company’s medicines and transform patient lives. In this article we explore examples of blocks to access and how they can be addressed to drive value for patients, the NHS and the sponsoring Pharmaceutical Company.

Where is the Block?

October 2022

Driving access to medicines is proving to be more difficult and complicated than expected. In this article learn how new management processes and tools are required to customise local access strategies and drive access to your companies’ medicines.

Relieving the Burden of the NHS and Improving NHS Staff Wellbeing

July 2022

Pharmaceutical Companies are increasingly looking to support the NHS through the provision of services that deliver value to the NHS and its patients whilst driving access to the Companies medicines.

Avoiding Commoditisation through Innovation and Differentiation (Homecare Provision)

May 2022

The role of traditional promotional engagement strategies is being challenged by the new dawn of digital engagement.

Driving Access to Medicines and Reducing Waiting Lists

December 2021

Pharmaceutical Companies are facing unprecedented challenges in driving access to their medicines as a result of the Covid-19 Pandemic. How can Pharma help?

The Quickest Way to Access ‘Deep Dive’ Customer Insights

April 2021

In a complex and ever-changing healthcare environment, clients access strategies crucially depend on accelerated and deep insight into local and national healthcare economies. This insight is crucial at all stages of a medicine’s lifecycle both pre- and post-launch.

5 Key Success Factors in ensuring your Healthcare Programmes are adopted by the Market